{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:35:56Z","timestamp":1781069756622,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["work unit number E1025"],"award-info":[{"award-number":["work unit number E1025"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006090","name":"Center for Global Health","doi-asserted-by":"publisher","award":["work unit number E1025"],"award-info":[{"award-number":["work unit number E1025"]}],"id":[{"id":"10.13039\/100006090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3806-9","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T13:03:04Z","timestamp":1550149384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Evidence of sustained reductions in the relative risk of acute hepatitis B and C virus infections, and the increasing burden of hepatitis a virus infection in Egypt: comparison of sentinel acute viral hepatitis surveillance results, 2001\u201317"],"prefix":"10.1186","volume":"19","author":[{"given":"Maha","family":"Talaat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Afifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik J.","family":"Reaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanaa","family":"Abu Elsood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany","family":"El-Gohary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Refaey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radi","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Abdel Fadeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Kandeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"key":"3806_CR1","unstructured":"World Health Organization, 2017. Global Hepatitis Report, 2017. ISBN: 978\u201392\u20134-156545-5. Available at: \n                    http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/255017\/WHO-HIV-2017.06-eng.pdf.?sequence=1\n                    \n                  . Accessed 14 Nov 2018."},{"key":"3806_CR2","unstructured":"World Health Organization, 2009. Technical paper, the growing threats of hepatitis B and C in the Eastern Mediterranean Region: a call for action. EM\/RC56\/3, August, 2009. Available at \n                    http:\/\/applications.emro.who.int\/docs\/EM_RC56_3_en.pdf\n                    \n                  . Accessed 14 Nov 2018."},{"key":"3806_CR3","doi-asserted-by":"crossref","unstructured":"Mehdi Safiabadi, Mohammad Saeid Rezaee-Zavareh and Seyed Moayed Alavian. Estimation of Hepatitis A Virus Infection Prevalence Among Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Pooled Analysis, 2017. Hepat Mon 17(2):e44695.","DOI":"10.5812\/hepatmon.44695"},{"key":"3806_CR4","unstructured":"Morbidity and Mortality Weekly Report, July 27, 2012. Progress towards prevention and control of Hepatitis C infection-Egypt, 2001\u20132012. MMWR 61(29);545\u2013549. Available at: \n                    https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6129a2.htm\n                    \n                  . Accessed 14 Nov 2018."},{"key":"3806_CR5","doi-asserted-by":"crossref","unstructured":"Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, Abu-Raddad, et al. 2016. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet. 388:1081\u20138.","DOI":"10.1016\/S0140-6736(16)30579-7"},{"key":"3806_CR6","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/j.1365-2893.2009.01115.x","volume":"16","author":"EM Lehman","year":"2009","unstructured":"Lehman EM, Wilson ML. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality. J Viral Hepat. 2009;16:650\u20138.","journal-title":"J Viral Hepat"},{"key":"3806_CR7","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1478-3231.2009.02204.x","volume":"31","author":"A Mostafa","year":"2010","unstructured":"Mostafa A, Taylor SM, el-Daly M, el-Hoseiny M, Bakr I, Arafa N, et al. Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections. Liver Int. 2010;31:560\u20136.","journal-title":"Liver Int"},{"key":"3806_CR8","unstructured":"El-Zanaty, Fatma and Ann Way, 2009. Egypt Demographic and Health Survey 2008. Cairo, Egypt: Ministry of Health, El-Zanaty and Associates, and Macro International. Available at: \n                    https:\/\/dhsprogram.com\/pubs\/pdf\/fr220\/fr220.pdf\n                    \n                  . Accessed 14 Nov 2018."},{"key":"3806_CR9","unstructured":"World Health Organization, 2009. The global prevalence of hepatitis A virus infection and susceptibility: a systematic review, WHO\/IVB\/10.01. Available at: \n                    http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/70180\/WHO_IVB_10.01_eng.pdf?sequence=1\n                    \n                   Accessed 14 Nov 2018."},{"issue":"5","key":"3806_CR10","first-page":"1028","volume":"14","author":"AM Al-Aziz","year":"2008","unstructured":"Al-Aziz AM, Awad MA. 2008. Seroprevalence of hepatitis a virus antibodies among a sample of Egyptian children. East Mediterr Health J. 2008 Sep-Oct;14(5):1028\u201335.","journal-title":"East Mediterr Health J"},{"key":"3806_CR11","unstructured":"Egypt\u2019s Ministry of Health and Population (MOHP). Plan of Action for the Prevention, Care & Treatment of Viral Hepatitis, Egypt, 2014\u20132018. Available at: \n                    http:\/\/www.emro.who.int\/images\/stories\/egypt\/VH_Plan_of_Action_FINAL_PRINT1.pdf\n                    \n                  . Accessed 14 Nov 2018."},{"key":"3806_CR12","unstructured":"Ministry of Health and Population [Egypt], El-Zanaty and Associates [Egypt], and ICF International. 2015. Egypt Health Issues Survey 2015. Cairo, Egypt and Rockville, Maryland, USA: Ministry of Health and Population and ICF International. Available at: \n                    https:\/\/dhsprogram.com\/pubs\/pdf\/FR313\/FR313.pdf\n                    \n                  . Accessed 14 Nov 2018."},{"issue":"1","key":"3806_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/liv.13186","volume":"37","author":"A Kandeel","year":"2017","unstructured":"Kandeel A, Genedy M, El-Refai S, Funk AL, Fontanet A, Talaat M. The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment. Liver Int. 2017;37(1):45\u201353.","journal-title":"Liver Int"},{"issue":"2","key":"3806_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.26719\/2010.16.2.134","volume":"16","author":"M Talaat","year":"2010","unstructured":"Talaat M, El-Sayed N, Kandeel A, Azab MA, Afifi S, Youssef FG, et al. Sentinel surveillance for patients with acute hepatitis in Egypt 2001-04. East Mediterr Health J. 2010;16(2):134\u201340.","journal-title":"East Mediterr Health J"},{"key":"3806_CR15","unstructured":"World Health Organization, 2016. Technical considerations and case definitions to improve surveillance for viral hepatitis: technical report. ISBN 978 92 4 154954 7. Available at: \n                    http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/204501\/9789241549547_eng.pdf?sequence=1\n                    \n                   Accessed 14 Nov, 2018."},{"issue":"40","key":"3806_CR16","first-page":"1385","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","unstructured":"Centers for Disease Control and Prevention. (CDC), 2011. Establishment of a viral hepatitis surveillance system \u2014 Pakistan 2009\u20132011. MMWR Morb Mortal Wkly Rep. 2011 Oct 14;60(40):1385\u201390.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"3806_CR17","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","volume":"17","author":"RG Newcombe","year":"1998","unstructured":"Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17(8):857\u201372.","journal-title":"Stat Med"},{"issue":"5","key":"3806_CR18","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jiph.2016.09.020","volume":"10","author":"M Koroglu","year":"2017","unstructured":"Koroglu M, Jacobsen KH, Demiray T, Ozbek A, Erkorkmaz U, Altindis M. Socioeconomic indicators are strong predictors of hepatitis a seroprevalence rates in the Middle East and North Africa. J Infect Public Health. 2017;10(5):513\u20137.","journal-title":"J Infect Public Health"},{"issue":"4","key":"3806_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153804","volume":"11","author":"Z Wang","year":"2016","unstructured":"Wang Z, Chen Y, Xie S, Lv H. Changing epidemiological characteristics of hepatitis a in Zhejiang Province, China: increased susceptibility in adults. PLoS One. 2016;11(4):e0153804.","journal-title":"PLoS One"},{"issue":"3","key":"3806_CR20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/clinids\/11.3.464","volume":"11","author":"MS Green","year":"1989","unstructured":"Green MS, Block C, Slater PE. Rise in the incidence of viral hepatitis in Israel despite improved socioeconomic conditions. Rev Infect Dis. 1989;11(3):464\u20139.","journal-title":"Rev Infect Dis"},{"issue":"2","key":"3806_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jcv.2011.06.011","volume":"52","author":"U P\u00e9rez-Sautu","year":"2011","unstructured":"P\u00e9rez-Sautu U, Costafreda MI, Lite J, Sala R, Barrabeig I, Bosch A, et al. Molecular epidemiology of hepatitis a virus infections in Catalonia, Spain, 2005-2009: circulation of newly emerging strains. J Clin Virol. 2011;52(2):98\u2013102.","journal-title":"J Clin Virol"},{"key":"3806_CR22","unstructured":"World Health Organization, 2018. Hepatitis A fact sheet. Available at: \n                    http:\/\/www.who.int\/mediacentre\/factsheets\/fs328\/en\/\n                    \n                  .Accessed 14 Nov 2018."},{"issue":"4","key":"3806_CR23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/jvh.12668","volume":"24","author":"W El-Akel","year":"2017","unstructured":"El-Akel W, El-Sayed MH, El Kassas M, El-Serafy M, Khairy M, Elsaeed K, et al. National treatment programme of hepatitis C in Egypt: hepatitis C virus model of care. J Viral Hepat. 2017;24(4):262\u20137.","journal-title":"J Viral Hepat"},{"key":"3806_CR24","unstructured":"WHO and UNICEF estimates of national immunization coverage, Egypt, 2017. Available at: \n                    https:\/\/data.unicef.org\/wp-content\/uploads\/country_profiles\/Egypt\/immunization_country_profiles\/immunization_egy.pdf\n                    \n                   Accessed 14 Nov 2018."},{"key":"3806_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/IJGM.S119301","volume":"10","author":"A Elgharably","year":"2017","unstructured":"Elgharably A, Gomaa AI, Crossey MM, Norsworthy PJ, Waked I, Taylor-Robinson SD. Hepatitis C in Egypt \u2013 past, present, and future. Int J Gen Med. 2017;10:1\u20136.","journal-title":"Int J Gen Med"},{"key":"3806_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2147\/HMER.S113681.","volume":"9","author":"A Gomaa","year":"2017","unstructured":"Gomaa A, Allam N, Elsharkway A, El Kassas M, Waked I. Hepatitis C infection in Egypt: prevalence, impact and management strategies. Hepat Med. 2017;9:17\u201325. \n                    https:\/\/doi.org\/10.2147\/HMER.S113681.","journal-title":"Hepat Med"},{"key":"3806_CR27","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/S0140-6736(06)69374-4","volume":"368","author":"J Amin","year":"2006","unstructured":"Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet. 2006;368:938\u201345.","journal-title":"Lancet"},{"issue":"9","key":"3806_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007193","volume":"4","author":"A Paez Jimenez","year":"2009","unstructured":"Paez Jimenez A, Mohamed MK, Sharaf Eldin N, Abou Seif H, El Aidi S, Sultan Y, et al. Injection drug use is a risk factor for HCV infection in urban Egypt. PLoS One. 2009;4(9):e7193.","journal-title":"PLoS One"},{"key":"3806_CR29","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/1471-2334-12-294","volume":"12","author":"AM Kandeel","year":"2012","unstructured":"Kandeel AM, Talaat M, Afifi SA, El-Sayed NM, Fadeel MAA, Hajjeh RA, et al. Case control study to identify risk factors for acute hepatitis C virus infection in Egypt. BMC Infect Dis. 2012;12:294.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"3806_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.26719\/2010.16.1.4","volume":"16","author":"M Talaat","year":"2010","unstructured":"Talaat M, Radwan E, El-Sayed N, Ismael T, Hajjeh R, Mahoney FJ. Case\u2013control study to evaluate risk factors for acute hepatitis B virus infection in Egypt. East Mediterr Health J. 2010;16(1):4\u20139.","journal-title":"East Mediterr Health J"},{"issue":"4","key":"3806_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ajic.2005.05.028","volume":"34","author":"M Talaat","year":"2006","unstructured":"Talaat M, Kandeel A, Rasslan O, Hajjeh R, Hallaj Z, El-Sayed N, Mahoney FJ. Evolution of infection control in Egypt: achievements and challenges. Am J Infect Control. 2006;34(4):193\u2013200.","journal-title":"Am J Infect Control"},{"key":"3806_CR32","unstructured":"European Association for the Study of the Liver(EASL), 2016. Recommendations on Treatment of Hepatitis C. Available at: http:\/\/www.easl.eu\/medias\/cpg\/HCV2016\/Summary.pdf Accessed 14 November, 2018."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3806-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3806-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3806-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T11:41:38Z","timestamp":1589456498000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3806-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,14]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3806"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3806-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,14]]},"assertion":[{"value":"25 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was reviewed and approved by the Institutional Review Board of U.S. Naval Medical Research Unit #3 (DOD# NAMRU3.2013.0005). Review Board approved the project as non-research activity not involving human research and thus informed consent was not required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"159"}}